Banced Corp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-7,527
Closed -$471K 33
2018
Q4
$471K Sell
7,527
-435
-5% -$30.4K 1.02% 36
2018
Q3
$615K Sell
7,962
-385
-5% -$29.1K 1.05% 27
2018
Q2
$591K Sell
8,347
-380
-4% -$26.8K 1.01% 31
2018
Q1
$657K Sell
8,727
-386
-4% -$30.7K 1.17% 22
2017
Q4
$653K Buy
9,113
+229
+3% +$17.4K 1.08% 24
2017
Q3
$720K Sell
8,884
-807
-8% -$61.7K 1.25% 17
2017
Q2
$686K Buy
9,691
+899
+10% +$59.8K 1.27% 19
2017
Q1
$597K Buy
8,792
+137
+2% +$9.63K 1.09% 27
2016
Q4
$620K Sell
8,655
-4,662
-35% -$347K 1.17% 23
2016
Q3
$1.05M Sell
13,317
-503
-4% -$40.9K 2.07% 7
2016
Q2
$1.36M Sell
13,820
-1,359
-9% -$121K 2.54% 2
2016
Q1
$1.4M Buy
15,179
+2,583
+21% +$233K 2.44% 3
2015
Q4
$1.27M Sell
12,596
-1,224
-9% -$127K 2.28% 3
2015
Q3
$1.36M Sell
13,820
-2,944
-18% -$327K 2.5% 2
2015
Q2
$1.96M Sell
16,764
-371
-2% -$40.5K 2.67% 2
2015
Q1
$1.68M Buy
17,135
+250
+1% +$25.4K 2.37% 2
2014
Q4
$1.59M Buy
16,885
+837
+5% +$86.6K 1.73% 4
2014
Q3
$1.71M Buy
16,048
+469
+3% +$45.9K 1.97% 3
2014
Q2
$1.29M Sell
15,579
-1,388
-8% -$108K 1.56% 3
2014
Q1
$1.2M Sell
16,967
-1,669
-9% -$131K 1.25% 8
2013
Q4
$1.4M Sell
18,636
-2,391
-11% -$166K 1.41% 6
2013
Q3
$1.32M Sell
21,027
-2,199
-9% -$131K 1.33% 11
2013
Q2
$1.19M Buy
+23,226
New +$1.21M 1.22% 14

Other funds holding GILD

Banced Corp's GILD Position: Q1 2019 in Review

Banced Corp sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 7,527 shares — an estimated $471K sold.

Banced Corp first reported a position in GILD in Q2 2013 and held it in 23 quarters. The position peaked at $1.96M in Q2 2015. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Banced Corp reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Banced Corp sold 7,527 Gilead Sciences shares in Q1 2019, an estimated $471K.
  • Banced Corp first reported a position in Gilead Sciences in Q2 2013 and held it in 23 quarters.
  • Banced Corp's Gilead Sciences position peaked at $1.96M in Q2 2015.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Banced Corp's 13F filing for Q1 2019.